-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A new study from Rutgers University will examine how COVID-19 affects individuals in a number of cognitive-related fields, including memory loss, "brain fog" and dementia
"Many people who have recovered from mild or moderate COVID-19 noticed slowed thinking or memory loss, which prompted us to use our research on cognitive problems related to Alzheimer’s disease, multiple sclerosis, and HIV.
As a leading cognitive neuroscientist and neuroscientist, Dr.
"We found that neuroinflammation is a common theme in many brain diseases, but not all neuroinflammation is the same," he pointed out
Dr.
Dr.
"The generous support from TMCity will accelerate this effort in New Brunswick, and it is possible to apply the technology more widely to other organs affected by long-term COVID, such as the heart and lungs," Dr.
The research builds on the work done by Dr.
In this project, about half of the patients developed brain fog problems after a battle with COVID
She said: "The neurocognitive consequences after the new coronary pneumonia affect the daily lives of 62% of patients
"Vaccines may help brain fog to some extent, but what I see from a clinical perspective is longer-term short-term memory loss," Dr.
She emphasized that the clinic is open to COVID-19 patients, regardless of whether they have active symptoms
To participate in the recovery plan after the new crown epidemic, please call 732-235-7840
